Lactobacillus reuteri DSM 17938 and Reduced All-Cause Mortality

• Limosilactobacillus reuteri DSM 17938 as a probiotic in preterm infants: An updated systematic review with meta-analysis and trial sequential analysis.

  • 2023-10-13
  • Meta-Analysis · n = 2,284
  • JPEN. Journal of parenteral and enteral nutrition 47(8)
  • • Ju Li Ang
    • Gayatri Athalye-Jape
    • Shripada Rao
    • Max Bulsara
    • Sanjay Patole

  • PubMed: 37742098
  • DOI: 10.1002/jpen.2564

  4 Insights on

  • Reduced All-Cause Mortality

  • High evidence
  • Infants

  Meta-analysis of RCTs showed LR did not significantly reduce mortality (RR, 0.76 [95% CI, 0.54-1.06]; P = 0.10)

  Effect

  Neutral

  Effect size

  Small

  Significant

  No